CONTENTS
Supplement 1
MELATONIN:
Clinical Significance and
Therapeutic Application
Editor:
Prof. M. Karasek,
M.D., Ph.D., Dr. h.c.
EDITORIAL
M. Karasek, Deputy Chief Editor
2002; 23 (suppl 1):1-2
INVITED
REVIEWS
R.J.
Reiter, D.X. Tan & M. Allegra:
Melatonin: reducing molecular pathology and dysfunction
due to "free radical and associated reactants
2002; 23 (suppl 1):3-8 HERE
D.P.
Cardinali, L.I. Brusco, S.P. Lloret & A.M. Furio:
Melatonin in sleep disorders and jet-lag
2002; 23 (suppl 1):9-13
M.
Karasek, R.J. Reiter:
Melatonin and aging
2002; 23 (suppl 1):14-16
D.P.
Cardinali, L.I. Brusco, C. Liberczuk & A.M. Furio:
The use of melatonin in Alzheimer's disease
2002; 23 (suppl 1):20-23
M.
Pawlikowski, K. Winczyk & M. Karasek:
Oncostatic action of melatonin: facts and question
marks
2002; 23 (suppl 1):24-29
C.
Bartsch, H. Bartsch & M. Karasek:
Melatonin in clinical oncology
2002; 23 (suppl 1):30-38
M.
Karbownik:
Potential Anticarcinogenic action of melatonin and
other antioxidants "mediated by antioxidative mechanisms
2002; 23 (suppl 1):39-44
K.
Skwarlo-Sonta:
Melatonin in immunity: comparative aspects
2002; 23 (suppl 1):61-66
A.
Lewinski & M. Karbownik:
Melatonin and the thyroid gland
2002; 23 (suppl 1):73-78
E.
Sewerynek:
Melatonin and the cardiovascular system
2002; 23 (suppl 1):79-83
M.
Karasek & A. Lerchl:
Melatonin and magnetic fields
2002; 23 (suppl 1):84-87
I.M.
Kvetnoy:
Extrapineal melatonin in pathology: new perspectives
for diagnosis, "prognosis, and treatment of illness
2002; 23 (suppl 1):92-96
ORIGINAL
ARTICLES
M.
Pawlikowski, M. Kolomecka, A. Wojtczak & M. Karasek:
Effects of six months melatonin treatment on sleep
quality and "serum concentrations of estradiol, cortisol,
dehydroepinadrosteron sulfate, "and somatomedin C
in elderly women
2002; 23 (suppl 1):17-19
A.
Rimler, Z. Lupowitz & N. Zisapel:
Differential regulation by melatonin of cell growth
and androgen receptor "binding to the androgen response
element in prostate cancer cells
2002; 23 (suppl 1):45-49
K.
Winczyk, M. Pawlikowski, H. Lawnicka, J. Kunert-Radek,
G. Spadoni,
G. Tarzia & M. Karasek:
Effect of melatonin and melatonin receptors ligand
"N-[(4-methoxy-1H-2-yl)methyl]propamide on murine
Colon 38 cancer growth in vitro and in vivo
2002; 23 (suppl 1):50-54
M.
Karasek, A. Carrillo-Vico, J.M. Guerrero, K. Winczyk &
M. Pawlikowski:
Expression of melatonin MT1 and MT2 receptors, and
ROR=1 receptor in transplantable murine Colon 38 cancer
2002; 23 (suppl 1):55-60
M.
Markowska, A. Mrozkowiak & K. Skwarlo-Sonta:
Influence of melatonin on chicken lymphocyte in vitro:
involvement of membrane receptors
2002; 23 (suppl 1):67-72
A.
Bortkiewicz, B. Pilacik, E. Gadzicka & W. Szymczak:
The excretion of 6-hydroxymelatonin sulfate in healthy
young men exposed to "electromagnetic fields emitted
by cellular phone - an experimental study
2002; 23 (suppl 1) 88-91
M.
Karasek, A. Szuflet, W. Chrzanowski, K. Zylinska &
J. Swietoslawski:
Circadian serum melatonin profiles in patients suffering
from chronic renal failure
2002; 23 (suppl 1):97-102
Z.
Ostrowska, B. Kos-Kudla, B. Marek, D. Kajdaniuk, P. Staszewicz,
B. Szapska & J. Strzelczyk:
The influence of pinealectomy and melatonin administration
on "the dynamic pattern of biochemical markers of
bone metabolism in experimental osteoporosis in the rat
2002; 23 (suppl 1):104-109
B.
Lewczuk:
Presynaptic autoregulation of norepinephrine release
from sympathetic "nerve fibres in the pineal gland
of the domestic pig. "Pharmacological characterization
of a2-adrenoceptors mediating
this process
2002; 23 (suppl 1):1-2 pii: NEL230702E01
PMID:
ROUND
TABLE CONFERENCE REPORT
M. Karasek, R.J. Reiter,
D.P. Cardinali & M. Pawlikowski:
The future of melatonin as a
therapeutic agent
pages: 118-121
|
